Successful Off-Label Long-Term Use of 0.02% Tacrolimus for the Maintenance of Corneal Graft Tolerance in a Congenital Glaucoma Steroid Responder

Protiva Khan


A steroid responder with congenital glaucoma presents status post DSAEK left eye with graft tolerance maintained with 0.02% Tacrolimus for 15 months. This case demonstrates successful long-term graft maintenance with off-label 0.02% Tacrolimus.


Year: 2017

Program Number: R2017228

Author Affiliation: State University of New York in New York City

Co-Authors: n/a

Co-Author Affiliation: n/a

Room: E354B